Sort
85,873 grants matching “alzheimers”
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for AlzheimerÂs Disease
$771,366Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · AG
Peptide Biomarkers for Alzheimer Disease
$771,363Jing Zhang · University Of Washington · R01 · FY2017 · AG
THE HUMAN BRAINOME III: EQTL REGULATION BY NATURAL ANTISENSE RNA IN ALZHEIMER S DISEASE
$771,340Amanda J Myers · University Of Miami School Of Medicine · R01 · FY2021 · AG
Brain Safe: Consumer Intervention to Reduce Exposure to Drugs Linked to Alzheimer's Disease
$771,262Richard J Holden · Indiana University Indianapolis · R01 · FY2019 · AG
Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults
$771,216Marian L Fitzgibbon · University Of Illinois At Chicago · R01 · FY2017 · HL
Biomarker Core
$771,181Leslie Michael Shaw · Northern California Institute/Res/Edu · U19 · FY2022 · AG
Scalable, all-optical assays of synaptic function and plasticity
$771,167Graham Thomas Dempsey · Q-State Biosciences, Inc. · R44 · FY2020 · MH
APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease
$771,160Jamie R Privratsky · Duke University · R01 · FY2024 · AG
Lipid imaging expansion microscopy to study Alzheimer's disease
$771,150Edward S. Boyden · Massachusetts Institute Of Technology · R01 · FY2024 · AG
Brain networks in mouse models of aging
$771,107Alexandra Badea · Duke University · R01 · FY2020 · AG
Genetic characterization of atypical parkinsonism
$771,084Sonja Scholz · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Clinical Core
$771,081Richard J O'Brien · Duke University · P30 · FY2024 · AG
Impaired activity-dependent protein synthesis in dendrites and pathophysiology in tauopathy
$771,040Tara Tracy · Buck Institute For Research On Aging · R01 · FY2025 · AG
Longitudinal MRI Investigation of Traumatic Microvascular Injury
$771,006Jeffrey B Ware · University Of Pennsylvania · R01 · FY2024 · NS
Metabolomic characterization of normal aging and Alzheimer's disease under anesthesia- surgery stimuli
$770,955Bruce Jenkins · Massachusetts General Hospital · R01 · FY2025 · AG
eAlign: A Patient Portal-based Intervention to Align Medications with What Matters Most
$770,908Ariel Green · Johns Hopkins University · R01 · FY2025 · AG
Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism
$770,897Wen-Quan Zou · Case Western Reserve University · U01 · FY2019 · NS
Care for Persons With Dementia in Nurse Practitioner Practices and Racial and Ethnic Health Disparities
$770,851Lusine Poghosyan · Columbia University Health Sciences · R01 · FY2022 · AG
Core C: Imaging Core
$770,841Keith A. Johnson · Massachusetts General Hospital · P01 · FY2016 · AG
Gene discovery in multi-ethnic late-onset Alzheimer's disease families
$770,831Badri N Vardarajan · Columbia University Health Sciences · U01 · FY2021 · AG
Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates
$770,793Michael R Weed · Virscio, Inc. · R44 · FY2021 · AG
Drug repurposing for Alzheimer's disease using structural systems pharmacology
$770,770Lei Xie · Hunter College · R56 · FY2017 · AG
Insulin Resistance and Accelerated Cognitive Aging
$770,740Natalie L Rasgon · Stanford University · R01 · FY2016 · AG
The impact of post acute care payment changes on access and outcomes
$770,738Natalie Elizabeth Leland · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AG
Production and Distribution of well-characterized polymorphic variants of alpha-synuclein aggregates
$770,698Claudio Soto · University Of Texas Hlth Sci Ctr Houston · U24 · FY2025 · AG